Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Nov 10, 2020.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | Director | Jun 5, 2024 | Aug 19, 2026 |
| Incyte (INCY) | Director | Jan 22, 2015 | Jun 10, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 17, 2026, Keros Therapeutics, Inc.: bought 1,000 shares for $10K. 1 filing: 1
- Jul 15, 2026, Keros Therapeutics, Inc.: bought 1,000 shares for $11K. 1 filing: 1
- Jun 15, 2026, Keros Therapeutics, Inc.: bought 1,000 shares for $10K. 1 filing: 1
- Jun 8, 2026, Incyte: 1,642 shares granted. 1 filing: 1
- Jun 3, 2026, Keros Therapeutics, Inc.: 7,142 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.